Hullinger TG - Search Results

1

Secretory products from PC-3 and MCF-7 tumor cell lines upregulate osteopontin in MC3T3-E1 cells.

Hullinger TG, Taichman RS, Linseman DA, Somerman MJ. Hullinger TG, et al. J Cell Biochem. 2000 Jun 12;78(4):607-16. doi: 10.1002/1097-4644(20000915)78:4<607::aid-jcb10>3.0.co;2-f. J Cell Biochem. 2000. PMID: 10861858 Free article.

2

Effect of bone proteins on human prostate cancer cell lines in vitro.

Hullinger TG, McCauley LK, DeJoode ML, Somerman MJ. Hullinger TG, et al. Prostate. 1998 Jun 15;36(1):14-22. doi: 10.1002/(sici)1097-0045(19980615)36:1<14::aid-pros3>3.0.co;2-b. Prostate. 1998. PMID: 9650911 Free article.

3

Bone morphogenetic proteins secreted by breast cancer cells upregulate bone sialoprotein expression in preosteoblast cells.

Bunyaratavej P, Hullinger TG, Somerman MJ. Bunyaratavej P, et al. Among authors: hullinger tg. Exp Cell Res. 2000 Nov 1;260(2):324-33. doi: 10.1006/excr.2000.5019. Exp Cell Res. 2000. PMID: 11035927

4

TGFbeta and BMP-2 activation of the OPN promoter: roles of smad- and hox-binding elements.

Hullinger TG, Pan Q, Viswanathan HL, Somerman MJ. Hullinger TG, et al. Exp Cell Res. 2001 Jan 1;262(1):69-74. doi: 10.1006/excr.2000.5074. Exp Cell Res. 2001. PMID: 11120606

5

Evolution of periodontal regeneration: from the roots' point of view.

Somerman MJ, Ouyang HJ, Berry JE, Saygin NE, Strayhorn CL, D'Errico JA, Hullinger T, Giannobile WV. Somerman MJ, et al. J Periodontal Res. 1999 Oct;34(7):420-4. doi: 10.1111/j.1600-0765.1999.tb02276.x. J Periodontal Res. 1999. PMID: 10685371 Free PMC article.

6

N-linked sialyated sugar receptors support haematopoietic cell-osteoblast adhesions.

Crean SM, Meneski JP, Hullinger TG, Reilly MJ, DeBoever EH, Taichman RS. Crean SM, et al. Among authors: hullinger tg. Br J Haematol. 2004 Feb;124(4):534-46. doi: 10.1046/j.1365-2141.2003.04786.x. Br J Haematol. 2004. PMID: 14984505 Free article.

7

p21-activated kinase-1 (PAK1) inhibition of the human scavenger receptor class B, type I promoter in macrophages is independent of PAK1 kinase activity, but requires the GTPase-binding domain.

Hullinger TG, Panek RL, Xu X, Karathanasis SK. Hullinger TG, et al. J Biol Chem. 2001 Dec 14;276(50):46807-14. doi: 10.1074/jbc.M103176200. Epub 2001 Oct 3. J Biol Chem. 2001. PMID: 11585816 Free article.

8

Inhibition of nitric oxide synthase prevents myocardial protection by ramiprilat.

Hartman JC, Kurc GM, Hullinger TG, Wall TM, Sheehy RM, Shebuski RJ. Hartman JC, et al. Among authors: hullinger tg. J Pharmacol Exp Ther. 1994 Sep;270(3):1071-6. J Pharmacol Exp Ther. 1994. PMID: 7523655

9

Reduction of myocardial infarct size in rabbits by ramiprilat: reversal by the bradykinin antagonist HOE 140.

Hartman JC, Wall TM, Hullinger TG, Shebuski RJ. Hartman JC, et al. Among authors: hullinger tg. J Cardiovasc Pharmacol. 1993 Jun;21(6):996-1003. doi: 10.1097/00005344-199306000-00022. J Cardiovasc Pharmacol. 1993. PMID: 7687728

10

Reduction of myocardial infarct size by ramiprilat is independent of angiotensin II synthesis inhibition.

Hartman JC, Hullinger TG, Wall TM, Shebuski RJ. Hartman JC, et al. Among authors: hullinger tg. Eur J Pharmacol. 1993 Apr 6;234(2-3):229-36. doi: 10.1016/0014-2999(93)90958-k. Eur J Pharmacol. 1993. PMID: 8482328

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

17 results

Search Page

Filters